FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2593007762> ?p ?o ?g. }

• W2593007762 endingPage "27488" @default.
• W2593007762 startingPage "27481" @default.
• W2593007762 abstract "// Hui Wang 1 , Yun Ti 1 , Jin-Bo Zhang 2 , Jie Peng 3 , Hui-Min Zhou 1 , Ming Zhong 1 , Yan-Qiu Xing 3 , Yun Zhang 1 , Wei Zhang 1 , Zhi-Hao Wang 3 1 The Key Laboratory of Cardiovascular Remodeling and Function Research, Chinese Ministry of Education and Chinese Ministry of Health, The State and Shandong Province Joint Key Laboratory of Translational Cardiovascular Medicine, Department of Cardiology, Qilu Hospital of Shandong University, Jinan, Shandong, 250012, P.R. China 2 Weihai Center for Diseases Control and Prevention, Weihai, Shandong, 264200, P.R. China 3 Department of Geriatrics, Qilu Hospital of Shandong University, Jinan, Shandong, 250012, P.R. China Correspondence to: Zhi-Hao Wang, email: wangzhihaosdu@126.com Keywords: metabolic syndrome, single nucleotide polymorphisms, risk factor, pharmacogenomics, drug treatment Received: September 07, 2016      Accepted: February 27, 2017      Published: March 10, 2017 ABSTRACT The association of single nucleotide polymorphisms rs1053239 and rs2479 of cell death-inducing DFFA-like effector c with the risk of metabolic syndrome and its components, and with the efficacy and cost-effectiveness of antihypertensive drugs was investigated. Totally 1064 subjects with metabolic syndrome and 1099 controls of Chinese Han nationality were recruited. Clinical assessment was conducted with medication records collected at baseline and during 5-year follow-up. Carriers of rs2479 A allele were at higher risk to develop elevated fasting glucose than non-carriers ( P = 0.004). A allele at rs2479 were associated with a 5-year aggravation of blood triglyceride ( P < 0.001) and diastolic blood pressure ( P = 0.003), and C allele at rs1053239 with the exacerbation of systolic ( P < 0.001) and diastolic blood pressure ( P = 0.001). Moreover, efficacy and cost-effectiveness of angiotensin II-targeted drugs were higher in subjects with rs2479 A allele or rs1053239 C allele. These findings suggest that carriers of rs2479 A allele are predisposed to the development of increased fasting glucose, and the progressive elevation of blood triglyceride. Individuals with A allele at rs2479 or C allele at rs1053239 are more susceptible to a rapid progression of blood pressure, and benefit more from angiotensin II-targeted therapy." @default.
• W2593007762 created "2017-03-16" @default.
• W2593007762 creator A5000398995 @default.
• W2593007762 creator A5023874610 @default.
• W2593007762 creator A5031378164 @default.
• W2593007762 creator A5032315085 @default.
• W2593007762 creator A5044650966 @default.
• W2593007762 creator A5052615768 @default.
• W2593007762 creator A5055607351 @default.
• W2593007762 creator A5061897648 @default.
• W2593007762 creator A5063415414 @default.
• W2593007762 creator A5090366405 @default.
• W2593007762 date "2017-03-10" @default.
• W2593007762 modified "2023-09-27" @default.
• W2593007762 title "Single nucleotide polymorphisms in CIDEC gene are associated with metabolic syndrome components risks and antihypertensive drug efficacy" @default.
• W2593007762 cites W1526318802 @default.
• W2593007762 cites W1896195310 @default.
• W2593007762 cites W1908352934 @default.
• W2593007762 cites W1963739832 @default.
• W2593007762 cites W1973359170 @default.
• W2593007762 cites W1975037124 @default.
• W2593007762 cites W1977801817 @default.
• W2593007762 cites W1978093763 @default.
• W2593007762 cites W1979122274 @default.
• W2593007762 cites W1983032962 @default.
• W2593007762 cites W1984170705 @default.
• W2593007762 cites W2002195419 @default.
• W2593007762 cites W2018330219 @default.
• W2593007762 cites W2018548355 @default.
• W2593007762 cites W2030251861 @default.
• W2593007762 cites W2046591933 @default.
• W2593007762 cites W2072551674 @default.
• W2593007762 cites W2102390567 @default.
• W2593007762 cites W2111361491 @default.
• W2593007762 cites W2143104968 @default.
• W2593007762 cites W2162530578 @default.
• W2593007762 cites W2170352583 @default.
• W2593007762 cites W2209445234 @default.
• W2593007762 cites W2230222215 @default.
• W2593007762 cites W2281629234 @default.
• W2593007762 cites W2300309871 @default.
• W2593007762 cites W2325075659 @default.
• W2593007762 cites W2336793907 @default.
• W2593007762 cites W2413417474 @default.
• W2593007762 cites W2531632716 @default.
• W2593007762 doi "https://doi.org/10.18632/oncotarget.16078" @default.
• W2593007762 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5432350" @default.
• W2593007762 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28415694" @default.
• W2593007762 hasPublicationYear "2017" @default.
• W2593007762 type Work @default.
• W2593007762 sameAs 2593007762 @default.
• W2593007762 citedByCount "5" @default.
• W2593007762 countsByYear W25930077622018 @default.
• W2593007762 countsByYear W25930077622020 @default.
• W2593007762 countsByYear W25930077622021 @default.
• W2593007762 countsByYear W25930077622022 @default.
• W2593007762 countsByYear W25930077622023 @default.
• W2593007762 crossrefType "journal-article" @default.
• W2593007762 hasAuthorship W2593007762A5000398995 @default.
• W2593007762 hasAuthorship W2593007762A5023874610 @default.
• W2593007762 hasAuthorship W2593007762A5031378164 @default.
• W2593007762 hasAuthorship W2593007762A5032315085 @default.
• W2593007762 hasAuthorship W2593007762A5044650966 @default.
• W2593007762 hasAuthorship W2593007762A5052615768 @default.
• W2593007762 hasAuthorship W2593007762A5055607351 @default.
• W2593007762 hasAuthorship W2593007762A5061897648 @default.
• W2593007762 hasAuthorship W2593007762A5063415414 @default.
• W2593007762 hasAuthorship W2593007762A5090366405 @default.
• W2593007762 hasBestOaLocation W25930077621 @default.
• W2593007762 hasConcept C104317684 @default.
• W2593007762 hasConcept C126322002 @default.
• W2593007762 hasConcept C135763542 @default.
• W2593007762 hasConcept C138885662 @default.
• W2593007762 hasConcept C142724271 @default.
• W2593007762 hasConcept C153209595 @default.
• W2593007762 hasConcept C170734499 @default.
• W2593007762 hasConcept C188947578 @default.
• W2593007762 hasConcept C204787440 @default.
• W2593007762 hasConcept C27206212 @default.
• W2593007762 hasConcept C2780578515 @default.
• W2593007762 hasConcept C511355011 @default.
• W2593007762 hasConcept C521751864 @default.
• W2593007762 hasConcept C54355233 @default.
• W2593007762 hasConcept C556039675 @default.
• W2593007762 hasConcept C71924100 @default.
• W2593007762 hasConcept C86803240 @default.
• W2593007762 hasConcept C98274493 @default.
• W2593007762 hasConceptScore W2593007762C104317684 @default.
• W2593007762 hasConceptScore W2593007762C126322002 @default.
• W2593007762 hasConceptScore W2593007762C135763542 @default.
• W2593007762 hasConceptScore W2593007762C138885662 @default.
• W2593007762 hasConceptScore W2593007762C142724271 @default.
• W2593007762 hasConceptScore W2593007762C153209595 @default.
• W2593007762 hasConceptScore W2593007762C170734499 @default.
• W2593007762 hasConceptScore W2593007762C188947578 @default.
• W2593007762 hasConceptScore W2593007762C204787440 @default.
• W2593007762 hasConceptScore W2593007762C27206212 @default.
• W2593007762 hasConceptScore W2593007762C2780578515 @default.

• next